Ignite Creation Date:
2025-12-25 @ 2:26 AM
Ignite Modification Date:
2026-03-28 @ 6:41 PM
Study NCT ID:
NCT06406634
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-04-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
Sponsor:
Hunan Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AK104-IIT-C-M-0035
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None